Cresco Labs (CRLBF) Net Income (2019 - 2026)
Cresco Labs (CRLBF) posted Net Income of -$17.0 million for Q1 2026, up 80.06% on a QoQ basis from -$85.3 million in Q4 2025, and down 11.68% year-over-year from -$19.3 million in Q1 2025.
Cresco Labs (CRLBF) Net Income (2019 - 2026) Analysis & Trends
Cresco Labs' Net Income history runs 8 years deep, the most recent figure standing at -$17.0 million for Q1 2026.
- Quarterly Net Income fell 11.68% year-over-year to -$17.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$138.2 million (down 87.62% YoY) and the FY2025 annual result came in at -$140.0 million, down 131.52% from the prior year.
- Net Income was -$17.0 million for Q1 2026 at Cresco Labs, up from -$85.3 million in the prior quarter.
- Across five years, Net Income topped out at $23.7 million in Q1 2022 and bottomed at -$180.6 million in Q4 2022.
- A 5-year average of -$35.9 million and a median of -$17.0 million in 2026 frame the typical range for Net Income.
- Annual changes were most pronounced in 2023 — Net Income soared 102.7% — and 2025, when it plunged 19539.86%.
- Cresco Labs' Net Income stood at -$180.6 million in 2022, then jumped by 102.7% to $4.9 million in 2023, then plunged by 90.98% to $439000.0 in 2024, then plunged by 19539.86% to -$85.3 million in 2025, then surged by 80.06% to -$17.0 million in 2026.
- Business Quant data shows CRLBF's Net Income at -$17.0 million in Q1 2026, -$85.3 million in Q4 2025, and -$22.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | -17.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.01 Mn |
| Dec 31, 2025 | -85.34 Mn |
| Sep 30, 2025 | -21.97 Mn |
| Jun 30, 2025 | -13.89 Mn |
| Mar 31, 2025 | -15.23 Mn |
| Dec 31, 2024 | 439,000.00 |
| Sep 30, 2024 | -7.69 Mn |
| Jun 30, 2024 | -51.18 Mn |
| Mar 31, 2024 | -2.06 Mn |
| Dec 31, 2023 | 4.87 Mn |
| Sep 30, 2023 | -113.45 Mn |
| Jun 30, 2023 | -43.46 Mn |
| Mar 31, 2023 | -27.81 Mn |
| Dec 31, 2022 | -180.62 Mn |
| Sep 30, 2022 | -3.25 Mn |
| Jun 30, 2022 | -55.65 Mn |
| Mar 31, 2022 | 23.68 Mn |
| Dec 31, 2021 | 35.15 Mn |
| Sep 30, 2021 | -219.60 Mn |
| Jun 30, 2021 | -45.60 Mn |